Syngenta and Athenix in R&D Partnership for Advanced Biotechnology Corn Insect and Soybean Nematode Control Traits
News Feb 01, 2008
Athenix is a US biotechnology company that develops products and technologies for agricultural and sustainable industrial applications. The agreement will allow Syngenta access to gene leads from which to develop advanced generation corn and soybean products.
Under the agreement, Athenix will screen its extensive microbial strain collection for the identification and initial development of novel gene leads in the targeted areas of corn rootworm, European corn borer, broad lepidopteran, and soybean cyst nematode control. The resultant gene leads will be provided to Syngenta for further development.
Syngenta will have exclusive global ownership on any corn and soybean transformation events developed using Athenix lead genes, excluding Australia and New Zealand. Athenix may further license gene leads it generates in the discovery process.
"The agreement with Athenix will extend Syngenta's strategy of offering growers multiple modes of action against a range of key pests in corn and soybeans," said David Lawrence, Syngenta Head of Global Research and Development.
"Athenix and Syngenta have proven track records in bringing traits to market, and this timely and important collaboration will help accelerate Syngenta's introduction of new technologies to unlock crop productivity," Lawrence added.
"We are pleased to work with a global agribusiness leader such as Syngenta to help bring our technical capabilities to commercialization," said Mike Koziel, Chief Executive Officer for Athenix. "This research and subsequent product offerings are important steps to providing growers and companies with more pest management choices."
Financial terms of the agreement were not disclosed.
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019